ARTV
Artiva Biotherapeutics, Inc. · Healthcare
RA CAPITAL MANAGEMENT, L.P. bought $1.4M of Artiva Biotherapeutics, Inc.
Director
Bought$1,432,119
$8.93Price
160,354Shares
+1%Stake
What ARTV did for a copier
- $1,000 copied at Tue, Jul 21 open, $9.78
- $1,156
- S&P 500, same days
- +2.5%
Measured over 30 trading days, to the Sep 2 close.
RA CAPITAL MANAGEMENT, L.P.'s record
63 other buys with 3 months of prices since 2016: on average +0.3% against the S&P 500, and 23 of 63 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, Jul 16. Filed Mon, Jul 20, 6:08 PM ET, after the close. Returns use the Jul 21 open and the Sep 2 close. Not investment advice.